More Post from the Author
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Joakim Weidemanis resigns from ASSA ABLOY's Board of Directors
STOCKHOLM, March 17, 2025 /PRNewswire/ -- Joakim Weidemanis has today, at his own request, resigned from ASSA ABLOY's Board of Directors. The reason is his commitment to another company.
He was elected to the ASSA ABLOY Board in 2020. After his departure, the Board will consist of seven members and will therefore remain decisive according to the company's articles of association.
For more information, please contact:
Nico Delvaux, President and CEO, tel.no:+46850648582
Erik Pieder, CFO and Executive Vice President, tel. no: +46 8 506 485 72
Bjrn Tibell, Head of Investor Relations, tel.no:+46 70275 67 68
About ASSA ABLOY
ASSA ABLOY is the global leader in access solutions. Every day we help people feel safe, secure and experience a more open world. We operate worldwide with 63,000 employees and sales of SEK 150 billion, with leading positions in areas such as efficient door openings, trusted identities and entrance automation. Our innovations enable safe, secure and convenient access to physical and digital places.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Press release (PDF) |

More Post from the Author
- LITO Announces New Collaboration Bringing Exclusive Contemporary Artist Editions to Sotheby's Online Marketplace
- SIRUI Wins "Best of Show", Unveils New Cine Lenses at NAB Show 2026
- Akemona to Power Upcoming Tokenized Offering for Industrialized Innovation Impact Portfolio I
- La vacunacin materna contra el VRS reduce el riesgo de hospitalizacin infantil en ms del 80%
- ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
